Moderna (Nasdaq: MRNA) today reported financial results and provided business updates for the first quarter of 2025, which ...

According to property advisor Knight Frank, venture capital (VC) funding into the UK life sciences sector reached £1.1 ...

UK investment firm Aviva Capital Partners is supporting a major new life sciences expansion in south London, which aims to ...

Shortly after Robert F Kennedy Jr was sworn in as Secretary of Health and Human Services (HHS), US President Donald Trump ...

UK regulators are set to review a proposed label update for Eisai (TYO: 4523) and Biogen’s (Nasdaq: BIIB) Alzheimer’s drug ...

UK pharma major GSK (LSE: GSK) has published results from its Phase III MATINEE trial evaluating Nucala (mepolizumab) in ...

The Russian drugmaker Akrikhin has filed a lawsuit against UK pharma major AstraZeneca (LSE: AZN) to the Moscow Intellectual ...

UK drugmaker GSK ended Tuesday’s trading more than 2% higher after announcing its first-quarter financial results.

US biotech major Biogen (Nasdaq: BIIB) reported stronger-than-expected earnings for the first quarter of 2025, helped by ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bristol Myers Squibb’s (NYSE: BMY) Opdivo ...

US biotech Immunic (Nasdaq: IMUX) has reported top-line results from a mid-stage study of its lead candidate vidofludimus ...

The US Food and Drug Administration (FDA) has approved Imaavy (nipocalimab-aahu), a human FcRn-blocking monoclonal antibody, ...